| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Zucero is an Australian-based biotechnology company focussed on the development of pixatimod, an immunotherapy for the treatment of cancer. Pixatimod successfully completed safety evaluation in a Phase 1a clinical trial. It is currently under investigation in a Phase 1b study in combination with Opdivo (immune checkpoint inhibitor) for pancreatic cancer, and new investigations in colon cancer is now being planned. |
| Category: | Hardware & devices, Health & biotech |
| URL: | http://www.zucero.com.au |
| Operational Status: | |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2016 |
| Address: | 1 Westlink Court, Suite 1.11, Level 1, Darra, Queensland 4076, AU |
| State: | Queensland |
| Overseas Operations: | |
| X: | |
| Facebook: | |
| Linkedin: | https://linkedin.com/company/zucero |
| Founders: |
No items found
|
| Awards won: | |
